143 related articles for article (PubMed ID: 16158306)
21. Effects of the Ru(III) complexes [mer-RuCl3(DMSO)2Im]degrees and Na[trans-RuCl4(DMSO)Im] on solid mouse tumors.
Sava G; Pacor S; Mestroni G; Alessio E
Anticancer Drugs; 1992 Feb; 3(1):25-31. PubMed ID: 1623212
[TBL] [Abstract][Full Text] [Related]
22. In vivo antitumor activity of bis(4,7-dimethyl-1,10-phenanthroline) sulfatooxovanadium(IV) (METVAN [VO(SO4)(Me2-Phen)2]).
Narla RK; Chen CL; Dong Y; Uckun FM
Clin Cancer Res; 2001 Jul; 7(7):2124-33. PubMed ID: 11448932
[TBL] [Abstract][Full Text] [Related]
23. Antitumor activity, distribution, and metabolism of 13-cis-retinoic acid as a single agent or in combination with tamoxifen in established human MCF-7 xenografts in mice.
Conley BA; Ramsland TS; Sentz DL; Wu S; Rosen DM; Wollman M; Eiseman JL
Cancer Chemother Pharmacol; 1999; 43(3):183-97. PubMed ID: 9923548
[TBL] [Abstract][Full Text] [Related]
24. Antitumor activity of platinum(II) complexes with histamine and radioiodinated histamine in a transplantable murine adenocarcinoma model.
Garnuszek P; Karczmarczyk U; Maurin M
Nucl Med Biol; 2008 Jul; 35(5):605-13. PubMed ID: 18589305
[TBL] [Abstract][Full Text] [Related]
25. In vitro and in vivo evaluation of ruthenium(II)-arene PTA complexes.
Scolaro C; Bergamo A; Brescacin L; Delfino R; Cocchietto M; Laurenczy G; Geldbach TJ; Sava G; Dyson PJ
J Med Chem; 2005 Jun; 48(12):4161-71. PubMed ID: 15943488
[TBL] [Abstract][Full Text] [Related]
26. Preclinical antitumor activity of an alpha-picoline derivative, penclomedine (NSC 338720), on human and murine tumors.
Plowman J; Harrison SD; Dykes DJ; Paull KD; Narayanan VL; Tobol HK; Martin J; Griswold DP
Cancer Res; 1989 Apr; 49(8):1909-15. PubMed ID: 2702634
[TBL] [Abstract][Full Text] [Related]
27. Antitumor activity of edotecarin in breast carcinoma models.
Ciomei M; Croci V; Stellari F; Amboldi N; Giavarini R; Pesenti E
Cancer Chemother Pharmacol; 2007 Jul; 60(2):229-35. PubMed ID: 17089166
[TBL] [Abstract][Full Text] [Related]
28. Antitumor activity of ZD1694 (tomudex) against human head and neck cancer in nude mouse models: role of dosing schedule and plasma thymidine.
Cao S; McGuire JJ; Rustum YM
Clin Cancer Res; 1999 Jul; 5(7):1925-34. PubMed ID: 10430100
[TBL] [Abstract][Full Text] [Related]
29. Antitumor effect of some rhodium(I) derivatives on MCa mammary carcinoma.
Sava G; Pacor S; Ceschia V; Zassinovich G; Mestroni G
Anticancer Res; 1989; 9(3):787-90. PubMed ID: 2764524
[TBL] [Abstract][Full Text] [Related]
30. Chiral cyclopalladated complexes derived from N,N-dimethyl-1-phenethylamine with bridging bis(diphenylphosphine)ferrocene ligand as inhibitors of the cathepsin B activity and as antitumoral agents.
Bincoletto C; Tersariol IL; Oliveira CR; Dreher S; Fausto DM; Soufen MA; Nascimento FD; Caires AC
Bioorg Med Chem; 2005 Apr; 13(8):3047-55. PubMed ID: 15781414
[TBL] [Abstract][Full Text] [Related]
31. Carcinostatic activity of methylglyoxal and related substances in tumour-bearing mice.
Conroy PJ
Ciba Found Symp; 1978; (67):271-300. PubMed ID: 159813
[TBL] [Abstract][Full Text] [Related]
32. Toxicity of aziridinylbenzoquinone for aerobic and hypoxic cells of a transplanted mouse mammary tumor and interaction of the drug with radiation and adriamycin.
Tannock I
Cancer Res; 1983 May; 43(5):2059-62. PubMed ID: 6831436
[TBL] [Abstract][Full Text] [Related]
33. Effect of docetaxel on the therapeutic ratio of fractionated radiotherapy in vivo.
Mason KA; Kishi K; Hunter N; Buchmiller L; Akimoto T; Komaki R; Milas L
Clin Cancer Res; 1999 Dec; 5(12):4191-8. PubMed ID: 10632360
[TBL] [Abstract][Full Text] [Related]
34. Tumor-inhibiting potential of ZK 112.993, a new progesterone antagonist, in hormone-sensitive, experimental rodent and human mammary tumors.
Schneider MR; Michna H; Nishino Y; Neef G; el Etreby MF
Anticancer Res; 1990; 10(3):683-7. PubMed ID: 2369083
[TBL] [Abstract][Full Text] [Related]
35. Antitumor efficiency of novel fluoro-substituted 6-amino-2-phenylbenzothiazole hydrochloride salts in vitro and in vivo.
Stojkovic R; Karminski-Zamola G; Racane L; Tralic-Kulenovic V; Glavas-Obrovac L; Ivankovic S; Radacic M
Methods Find Exp Clin Pharmacol; 2006; 28(6):347-54. PubMed ID: 16894403
[TBL] [Abstract][Full Text] [Related]
36. In vitro and in vivo assessments of two novel hydrazide compounds against breast cancer as well as mammary tumor cells.
Mousavi E; Tavakolfar S; Almasirad A; Kooshafar Z; Dehghani S; Afsharinasab A; Amanzadeh A; Shafiee S; Salimi M
Cancer Chemother Pharmacol; 2017 Jun; 79(6):1195-1203. PubMed ID: 28451832
[TBL] [Abstract][Full Text] [Related]
37. Isolation of a murine metastatic cell line and preliminary test of sensitivity to the anti-metastasis agent NAMI-A.
Pacor S; Vadori M; Vita F; Bacac M; Soranzo MR; Zabucchi G; Sava G
Anticancer Res; 2001; 21(4A):2523-30. PubMed ID: 11724317
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and antitumor evaluation of 2,5-disubstituted-indazolo[4, 3-gh]isoquinolin-6(2H)-ones (9-aza-anthrapyrazoles).
Krapcho AP; Menta E; Oliva A; Di Domenico R; Fiocchi L; Maresch ME; Gallagher CE; Hacker MP; Beggiolin G; Giuliani FC; Pezzoni G; Spinelli S
J Med Chem; 1998 Dec; 41(27):5429-44. PubMed ID: 9876113
[TBL] [Abstract][Full Text] [Related]
39. Schedule dependence of combretastatin A4 phosphate in transplanted and spontaneous tumour models.
Hill SA; Chaplin DJ; Lewis G; Tozer GM
Int J Cancer; 2002 Nov; 102(1):70-4. PubMed ID: 12353236
[TBL] [Abstract][Full Text] [Related]
40. Multiplexed gene silencing in living cells and in vivo using a DNAzymes-CoOOH nanocomposite.
Li N; Li Y; Gao X; Yu Z; Pan W; Tang B
Chem Commun (Camb); 2017 May; 53(36):4962-4965. PubMed ID: 28422198
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]